What RSV Symptoms Look Like in 2025
Respiratory syncytial virus (RSV) remains a common cause of respiratory illness in people of all ages. In 2025, RSV symptoms in older children and adults often resemble a cold or flu, with runny nose, cough, sore throat, and mild fatigue. Most recover at home with rest and supportive care, but some people—especially older adults and those with certain chronic conditions—are at higher risk of more serious disease. Understanding typical signs, differences from other viruses, and when to seek medical attention can help you respond safely and effectively.
Common RSV Symptoms by Age Group
Infants and Young Children
In infants and very young children, RSV often presents with bronchiolitis or pneumonia. Key features include rapid or difficult breathing, wheezing, chest retractions (skin pulling in around the ribs), persistent cough, poor feeding, and fewer wet diapers due to dehydration. Fever may be present but is not always high. Some infants become fussy, lethargic, or have pauses in breathing (apnea), particularly in younger preemies. Because these signs can develop quickly, early medical evaluation is important.
Older Children, Adults, and Older Adults
In older children and adults, RSV commonly causes upper- and lower-respiratory symptoms similar to colds or influenza. These can include runny or stuffy nose, dry or productive cough, sore throat, headache, low-grade fever, mild fatigue, and muscle aches. Wheezing is less common than in young children but can occur, especially in people with asthma or chronic lung disease. Older adults and those with weakened immune systems or heart and lung conditions are more likely to develop severe lower-respiratory illness such as pneumonia and may require hospitalization.
RSV vs Cold vs Flu: Quick Comparison
While symptoms overlap, certain patterns can help distinguish RSV from a common cold and influenza in non-severe cases:
- RSV tends to cause more prominent wheezing and downward progression into the chest (bronchiolitis), especially in young children, whereas colds mainly affect the nose and throat.
- Influenza often comes on more suddenly with higher fever, body aches, and systemic illness, while RSV symptoms may build more gradually and center on breathing difficulties.
- Cold symptoms are typically milder and more upper-respiratory, while both RSV and flu can cause lower-respiratory involvement; however, RSV is a common cause of pneumonia and wheezing in infants.
When to Test for RSV
Testing is typically considered when someone has respiratory symptoms and is at higher risk of complications, when symptoms are moderate to severe, or when clinical decisions such as hospitalization or specific therapies may be influenced by results. Common testing methods include nasal swabs or washes that detect viral antigens or nucleic acids. In 2025, multiplex respiratory panels used in clinics and hospitals can detect RSV alongside other common respiratory viruses, helping clinicians differentiate causes of illness. For most otherwise healthy people with mild symptoms, testing may not change home management, but it can be valuable for high-risk individuals and in care settings.
When to Seek Medical Care
Seek prompt medical attention if you or your child show any of the following:
- Fast, noisy, or difficult breathing, or ribs pulling in with each breath (retractions).
- Persistent cough, wheezing, or chest congestion that worsens.
- Blue or gray color to the lips, face, or nail beds (indicating low oxygen).
- Dehydration signs: not drinking, dry mouth, significantly fewer wet diapers or urination, or dizziness when standing.
- Fever that rises above 103°F (39.4°C) or lasts more than a few days, or fever that goes away and then returns.
- Unusual drowsiness, confusion, irritability, or difficulty waking.
- Symptoms that improve and then worsen again, which can signal a secondary infection.
RSV Severity and Risk Factors
RSV can cause mild illness or, in higher-risk groups, severe lower-respiratory infection requiring medical care. In 2025, key risk factors remain consistent with earlier years and include:
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Age: Infants (especially preemies) and children under 2 | Immature lungs and immune systems; higher rates of hospitalization | Clinical guidelines and surveillance data |
| Age: Adults 65 years and older | Higher risk of severe disease, pneumonia, and death | Clinical guidelines and surveillance data |
| Chronic lung disease (e.g., asthma, COPD, bronchopulmonary dysplasia) | Increased likelihood of wheezing and respiratory distress | Clinical studies and cohort data |
| Heart or immune system conditions | Greater risk of progression to severe infection | Clinical studies and cohort data |
| Prematurity or certain neurodevelopmental conditions | Higher apnea and respiratory-monitoring needs | Clinical guidelines |
Prevention, Home Care, and What to Expect
There is no specific antiviral treatment for RSV in otherwise healthy children and adults, so care focuses on symptom relief and monitoring. Helpful measures include staying hydrated, using saline drops and suction for nasal congestion, cool-mist humidifiers, and, when appropriate, age-appropriate fever reducers like acetaminophen or ibuprofen (following label guidance and clinician advice for infants). To protect others, practice good hand hygiene, cover coughs and sneezes, clean high-touch surfaces, and consider masking around high-risk people during periods of illness. In high-risk infants and young children, monthly monoclonal antibody protection may be recommended during RSV season, depending on local guidance and individual risk; discuss this with your pediatrician. Most people recover within 1 to 2 weeks, though cough and fatigue can linger slightly longer.
Key Takeaways on RSV Symptoms in 2025
- RSV commonly presents as runny nose, cough, sore throat, and fatigue in older children and adults; infants may show rapid breathing, retractions, wheezing, and poor feeding.
- Older adults and people with chronic heart or lung disease or weakened immune systems are at higher risk of severe disease and should seek early care for breathing difficulties.
- Testing can help guide clinical decisions during moderate to severe illness or for high-risk patients; many mild cases are managed with supportive home care.
- Prevention includes hand hygiene, surface cleaning, masking around vulnerable people, and, for selected infants, monoclonal antibody protection during RSV season.
Looking Ahead: Diagnosis, Care, and Public Health Context
In 2025, awareness of RSV within seasonal respiratory illness patterns remains important, especially as testing capabilities expand and monoclonal antibody options become more available for eligible infants. Public health and clinical guidance emphasize risk-stratified care: identifying who is more likely to develop severe disease, using testing when it changes management, and supporting recovery at home when appropriate. Staying informed about local RSV activity and discussing prevention strategies with your healthcare provider—particularly before peak seasons—can help reduce risk and ensure timely care if needed.